F23-9339962-1/140002/1

Abbvie Biotechnology Gmbh — FEI 3011277200

Refusal Details

Date
September 3, 2025
Country
Germany
Product Category
Drugs and Biologics
Product Code
58MCY09 RISANKIZUMAB-RZAA
Charges
75